Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event
    Summit & Event ：
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
    Learn More>
    Wealth & Capital Management
    Insurance & Finance
    Healthcare & Pharma
    Retail & FMCG
    Travel & Transportation
  • Shine Speaker Bureau
    Shine Speaker Bureau：
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
    Learn More>
    The Leader Networks
    Advisor
    Think-Tank
  • Shine Advisor
    Shine Advisor：
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
    Learn More>
    Briefing
    Consensus
    Customized Research
  • Shine Event Service
    Shine Event Service：
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
    Learn More>
Guest Information
Wubin Pan
Wubin Pan
发布时间: 2017 - 11 - 01
点击次数: 0
Positions： President
Company： Suzhou Connect biopharma
个人简介：
Dr. Pan has 20 years experiences in bioscience in North America and China, with extensive experiences in new drug R&D, as well as management, operation and fund raising. He joined TsingHua YuanXing Biopharmaceutical Co. Ltd. in 2000 as vice president and co-founded and served as VPs and general manager for a couple of biotech companies, where he played key role for the development of several gene-based biologics and was involved in the development and successfully marketing of a few biomedical products. In 2006, Dr. Pan co-founded Crown Bioscience, Inc., a leading CRO in oncology drug discovery where he worked as Chief Operation Officer, Executive Vice President and the President of Greater China. In 2012, he co-founded Connect Biopharmaceuticals, Ltd., an immune-modulator drug R&D Biotech successfully moved a few programs into clinical research by leveraging high quality support from multiple CROs. Dr. Pan obtained his Ph.D. in Biology in Sussex University (UK) and worked as a postdoctoral researcher at University of California at Berkeley.
查看详情>>
Zhenrong Guo
Zhenrong Guo
发布时间: 2017 - 11 - 01
点击次数: 0
Positions： Senior VP, CEO of CDMO Division
Company： Zhejiang Jiuzhou Pharmaceutical Co.,Ltd.
个人简介：
Dr. Zhenrong Guo is the senior vice president of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. and president of CDMO Division. He previously served as vice president at Sundia MediTech Company, Ltd. He was a senior researcher investigator and research project manager at Bristol-Myers Squibb. He most recently served as vice president at Apeloa pharmaceutical Co. and executive vice president at Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.  Dr. Guo is currently serving as the experts for the Ministry of Science and Technology and the Science and Technology Department of Zhejiang Province. He is also serving as the review experts for the National "13th Five-Year Plan of Science and Technology Major Project for New Drug Creation" and National "13th five-Year Plan" Major Projects for Precision Medicine. Dr. Guo has engaged in pharmaceutical R&D, GMP manufacturing, product quality, and regulatory filing for more than 25 years including Phase I to III for new drug development and NDA for new drug launch. Dr. Guo has published over 50 papers and patents in US and China. His research interests focus on anti-tumor, diabetes and Alzheimer's disease. While at Bristol-Myers Squibb, Dr. Guo made significant contributions for 2 new drugs launched in US and worldwide in 2007 and 2012, respectively. Dr. Guo has extensive experience in FDA, EU, WHO, and CFDA regulatory affairs and hand-on experience on handling FDA, EU, WHO, Japan PMDA, and Chinese FDA authorities on-site inspections. Dr. Guo received his Ph.D. from The University of Western Ontario, MBA from Fairleigh Dickinson University, and postdoctoral fellows from University of California at Berkeley and Monell Chemical Senses Center.
查看详情>>
Ting Xu
Ting Xu
发布时间: 2017 - 10 - 20
点击次数: 0
Positions： CEO
Company： Alphamab（Jiangsu）Biophamaceuticals Co.,Ltd
个人简介：
徐霆博士1997 年获得中科院物理所理学博士学位，1998 至2001年在哈佛大学等从事博士后研究。2001年至2008 年期间分别担任Archemix，Serono和Biogen 公司资深首席研究员等职位。徐霆博士。在对蛋白质药物筛选、表达、纯化、分析、质控及动物药理毒理等方面具有丰富的经验和独特的见解，发表了多篇关于蛋白质化学的具有重要创新性的研究论文。参与开发的多个蛋白质工程药物已经在欧美上市或处在临床阶段。   2008年，徐霆回国创业，先后成立康宁杰瑞（吉林）生物科技有限公司，苏州康宁杰瑞生物科技有限公司和苏州丁孚靶点生物科技有限公司，带领团队建立了多个自有知识产权的研发平台，并以此为基础完成了四十多个药物品种的研究开发，向国内大医药企业转让项目近20项，已有6项获得临床批件，自主申报临床批件7项，申请专利50多项。      徐霆博士2013年获得中组部千人计划特聘专家称号，担任中科院上海药物所客座研究员和东南大学生科院产业教授。
查看详情>>
Shoubai Chao
Shoubai Chao
发布时间: 2017 - 10 - 20
点击次数: 0
Positions： vice president
Company： Prior to joining Medimmune, Dr. Chao served as assistant vice president, Technical Operations and Product Supply at Wyeth Biotech. He was responsible for global technical operations for the flagship vaccine, Prevnar(R) and other Biopharmaceuticals. He brings comprehensive perspective with more than 20 years experience at Medimmune, Wyeth, Sanofi-Pasteur and Genentech in global vaccine and biopharmaceutical process and product development, manufacturing operations and quality assurance. The Chinese Biopharmaceutical Association-USA
个人简介：
Prior to joining Medimmune, Dr. Chao served as assistant vice president, Technical Operations and Product Supply at Wyeth Biotech. He was responsible for global technical operations for the flagship vaccine, Prevnar(R) and other Biopharmaceuticals. He brings comprehensive perspective with more than 20 years experience at Medimmune, Wyeth, Sanofi-Pasteur and Genentech in global vaccine and biopharmaceutical process and product development, manufacturing operations and quality assurance. Prior to joining Medimmune, Dr. Chao served as assistant vice president, Technical Operations and Product Supply at Wyeth Biotech. He was responsible for global technical operations for the flagship vaccine, Prevnar(R) and other Biopharmaceuticals. He brings comprehensive perspective with more than 20 years experience at Medimmune, Wyeth, Sanofi-Pasteur and Genentech in global vaccine and biopharmaceutical process and product development, manufacturing operations and quality assurance. Prior to joining Medimmune, Dr. Chao served as assistant vice president, Technical Operations and Product Supply at Wyeth Biotech. He was responsible for global technical operations for the flagship vaccine, Prevnar(R) and other Biopharmaceuticals. He brings comprehensive perspective with more than 20 years experience at Medimmune, Wyeth, Sanofi-Pasteur and Genentech in global vaccine and biopharmaceutical process and product development, manufacturing operations and quality assurance.
查看详情>>